Trials Sponsors Conditions Drugs Pricing

Conditions

Neonatal Seizure

Outcome Measures

Primary Outcomes (1)

prevalence of neonatal seizures among neonates admitted to Assiut University children's hospital
prevalence of neonatal seizures among neonates admitted to Assiut University children's hospital during period of study
1 year

Secondary Outcomes (1)

number of patients with controlled seizures during hospital admission period
1 year

Study Arms (2)

neonatal seizures cases

Cases of neonatal seizures

Diagnostic Test: blood and CSF studies + neuroimaging studies

seizure-free neonates

cases that are seizure free

Diagnostic Test: blood and CSF studies + neuroimaging studies

Interventions

blood and CSF studies + neuroimaging studiesDiagnostic test

blood and CSF studies + neuroimaging studies

neonatal seizures casesseizure-free neonates

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age1 Day - 1 Month

Sexall

Age GroupsChild (0-17)

Sampling MethodNon-Probability Sample

Study Population

ALL neonates (preterm and full-term infants) aged 0 to 28 days who are admitted to the neonatal intensive care unit of Assiut University Children's hospital

You may qualify if:

ALL neonates (preterm and full-term infants) aged 0 to 28 days who are admitted to the neonatal intensive care unit of Assiut University Children's hospital during the period of the study will be included

You may not qualify if:

Sponsors & Collaborators

Assiut University
Otherlead

Biospecimen

Retention: SAMPLES WITHOUT DNA

* CBC * Serum electrolytes (Serum Glucose, Serum Calcium , Serum Magnesium ) * Liver function tests * Blood urea and Serum Creatinine * Blood gases * CSF only (in suspected cases of CNS infections) * Serum ammonia and lactate levels for neonates suspected to have inborn errors of metabolism (extended metabolic screen if possible) * TORCH screening

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: principal investigator

Study Record Dates

First Submitted

February 7, 2022

First Posted

February 25, 2022

Study Start

July 2022

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

August 2023

Neonatal Seizures in NICU of Assuit University Children's Hospital

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

neonatal seizures cases

seizure-free neonates

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

neonatal seizures cases

seizure-free neonates

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record